B

Binghe Xu

Chinese Academy of Medical Sciences & Peking Union Medical College

ORCID: 0000-0002-0234-2747

Publishes on Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies. 259 papers and 5.9k citations.

PubIndex Score72Top 28% · seniorHow it's scored

259Publications

5.9kTotal Citations

First publication: 1998First senior author: 2007

Cancer Treatment and Pharmacology Breast Cancer Treatment Studies Advanced Breast Cancer Therapies HER2/EGFR in Cancer Research Lung Cancer Treatments and Mutations

Top publicationsby citations

Targeted therapeutic options and future perspectives for HER2-positive breast cancer

Jiani Wang, Binghe Xu|Signal Transduction and Targeted Therapy|2019

Cited by 406

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer

Zongbi Yi, Fei Ma, Lianpeng Chang et al.|npj Breast Cancer|2020

Cited by 74

Molecular landscape of <scp><i>TP53</i></scp> mutations in breast cancer and their utility for predicting the response to <scp>HER</scp>‐targeted therapy in <scp>HER2</scp> amplification‐positive and <scp>HER2</scp> mutation‐positive amplification‐negative patients

Binliang Liu, Yixin Zeng, Zongbi Yi et al.|Cancer Medicine|2022

Cited by 27